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Mitochondria are intracellular organelles that play a crucial
role in energy metabolism. Most cell energy is obtained
through mitochondrial metabolic pathways, especially the
Krebs cycle and electron transport chain which is the main
site for production of reactive oxygen species such as super-
oxide, hydrogen peroxide, and hydroxyl radicals. Brain tissue
is highly sensitive to oxidative stress due to its high oxy-
gen consumption, iron and lipid contents, and low activity
of antioxidant defenses. Thus, energy metabolism impair-
ment and oxidative stress are important events that have been
related to the pathogenesis of diseases affecting the central
nervous system.
In the present issue, the pathogenesis of common
Alzheimer’s (AD) and Parkinson’s (PD) diseases is addressed
in five papers. Mondrago´n-Rodr´ıguez et al. proposed that
phosphorylated tau protein could play the role of potential
connector and that a combined therapy involving antioxi-
dants and check points for synaptic plasticity during early
stages of the disease could become a viable therapeutic
option for AD treatment. This paper is accompanied by a
study by T. Rohn that explores the potential role that the
triggering receptor expressed on myeloid cells 2 (TREM2)
normally plays and how loss of function may contribute to
AD pathogenesis by enhancing oxidative stress and inflam-
mation within the central nervous system. Additionally, O.
Myhre et al. review the possible impact of environmental
exposures in metal dyshomeostasis and inflammation in AD
and PD. Furthermore, T. Omura et al. explore recent studies
on the mechanism of endoplasmic reticulum stress-induced
neuronal death related to PD, focusing on the involvement of
human ubiquitin ligase HRD1 in the prevention of neuronal
death as well as a potential therapeutic approach for PD
based on the upregulation of HRD1. Lastly, S. Matsuda et al.
showed a concise overview on the cellular functions of the
mitochondrial kinase PINK1 and the relationship between
Parkinsonism and mitochondrial dynamics, with particular
emphasis on a mitochondrial damage response pathway and
mitochondrial quality control.
Three of the papers deal with aspects of oxidative stress
implicated in the pathogenesis of neurodegenerative diseases.
W. Liu et al. reviewed the current literature on the effects
of oxidative stress due to exhaustive training on uncoupling
protein 2 (UCP2) and Bcl-2/Bax in rat skeletal muscles. A.-
M. Enciu et al. explore the possibility of oxidative-induced
molecular mechanisms of blood-brain barrier disruption
and tight junction protein expression alteration, in relation
to aging and neurodegeneration. Moreover, M. Tajes et al.
suggest that peroxynitrite induces cell death and is a very
harmful agent in brain ischemia.
A. Hosseini and M. Abdollahi review the pathogenesis
of diabetic neuropathy with a focus on oxidative stress and
introduced therapies dependent or independent of oxidative
stress. A. Sekigawa et al. review the currently available evi-
dence that neither mitochondria nor leucine-rich repeat
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kinase 2 (LRRK2) was present in the swellings of mice
expressing P123H 𝛽-synuclein, suggesting that 𝛼- and 𝛽-
synucleins might play differential roles in the mitochondrial
pathology of 𝛼-synucleinopathies. The paper by P. F. Schuck
et al. showed that trans-glutaconic acid is toxic to brain cells
in vitro, by causing alterations in cell ion balance andprobably
neurotransmission, as well as oxidative stress in rat cerebral
cortex. To complete the issue, M. J. Rodr´ıguez et al. discuss
the mitochondrial KATP channel as a new target to control
microglia activity, avoid its toxic phenotype, and facilitate a
positive disease outcome. Fortes et al. showed that 5TIO1 can
protect the brain against neuronal damage regularly observed
during neuropathologies.These papers are accompanied by a
review by Z. Yu et al. on how the neuroglobin’s neuroprotec-
tion is related to mitochondria function and regulation.
By compiling these papers, we hope to enrich our readers
and researchers with respect to mitochondrial dysfunction,
energy metabolism impairment, and oxidative stress in the
pathophysiology of neurodegenerative diseases.
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